Online Resources/Supplementary Materials for the Article: Comparison of Adverse Events in Pregnant Persons receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis using Combined Data from US VAERS and Eudravigilance spontaneous repor
Supplementary Material Caption: ESM_1/Online Resource 1: Common Data Model to map VAERS and EV variables ESM_2/Online Resource 2: The READUS-PV checklist to enhance transparency, completeness and accuracy on the reporting of disproportionality analyses conducted using ICSR databases20 ESM 3/Online Resource 3: Frequency of pregnancy-ICSRs per country ESM 4/Online Resource 4: Most reported Maternal and Neonatal Outcome-High-level with complete list of PTs ESM 5/Online Resource 5: sensitivity analyses in VAERS and EV ESM_6/Online Resource 6: Key variables of SDRs for case-by-case analysis ESM_7/Online Resource 7: PRR estimates pr each HLT-vaccine combination Comparison of Adverse Events in Pregnant Persons receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis using Combined Data from US VAERS and Eudravigilance spontaneous report databases Drug Safety Journal Authors: Leonardo Roque-Pereira (0000-0002-5878-5088)1, Malede Mequanent Sisay1, Comfort K. Ogar2, Carlos E. Durán1(0000-0003-1853-3641), Eugene Van Puijenbroek3,5, Daniel Weibel1, Katia Verhamme4 , Miriam Sturkenboom1 Affiliation: 1 Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands 2 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands 3 University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, - Epidemiology & -Economics, The Netherlands 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands 5Pharmacovigilance centre Lareb, 's-Hertogenbosch, the Netherlands
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-03-05
- DOI
- https://doi.org/10.5281/zenodo.14976833
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00